---

Medical Advocates Ethics and Infectious Diseases
		Ethical Challenges Screening/Testing Refusal of Care/Services Detention Patient Exploitation Compulsory Treatment Decision-Making Reproduction Transplants End-of-Life Care Enteral Nutrition Professional Associations National Challenges         Sterilization Bioterrorism                     Prison Challenges HIV Exceptionalism           Conflicts of Interest Pharmaceutical Industry   Pregnancy HIV Prevention    Stigma Physician Reimbursement  Ethics and Disease Challenges and Duties HIV Cure Ebola Virus Disease Executions

---

Ethics Main Page

Main New and Noteworthy

Home Page

---

Medical Advocates Lamivudine (Epivir)   Main Page New and Noteworthy Lamivudine PI Drug Alerts Guidelines Database of ARV Drug Interactions Journal Data Conference Data Perinatal Data Pediatric Data ARV Drugs Main Page Main New/Newsworthy  Home Page       This web page is best viewed by using INTERNET EXPLORER Last Update:  April 01, 2017  Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader New and Noteworthy March 2017   Semi-continuous multi-step synthesis of lamivudine. Mandala D, Chada S, Watts P.Org Biomol Chem. 2017 Mar 31. Drug Alerts Lamivudine/Abacavir/Tenofovir Early Virologic Non-Response in Patients with HIV Infection Treated With Lamivudine, Abacavir and Tenofovir GSK July 2003 ARV Drugs Main Page Main New/Newsworthy  Home Page